Correlation Between TechPrecision Common and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both TechPrecision Common and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TechPrecision Common and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TechPrecision Common and Processa Pharmaceuticals, you can compare the effects of market volatilities on TechPrecision Common and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TechPrecision Common with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of TechPrecision Common and Processa Pharmaceuticals.

Diversification Opportunities for TechPrecision Common and Processa Pharmaceuticals

0.13

Correlation Coefficient

TechPrecision Common  Processa Pharmaceuticals

Average diversification

The 3 months correlation between TechPrecision and Processa is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding TechPrecision Common and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and TechPrecision Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TechPrecision Common are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of TechPrecision Common i.e., TechPrecision Common and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between TechPrecision Common and Processa Pharmaceuticals

Given the investment horizon of 90 days TechPrecision Common is expected to generate 0.54 times more return on investment than Processa Pharmaceuticals. However, TechPrecision Common is 1.86 times less risky than Processa Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest  246.00  in TechPrecision Common on April 27, 2025 and sell it today you would earn a total of  168.00  from holding TechPrecision Common or generate 68.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

TechPrecision Common  vs.  Processa Pharmaceuticals

TechPrecision Common

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in TechPrecision Common are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental indicators, TechPrecision Common unveiled solid returns over the last few months and may actually be approaching a breakup point.

Processa Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Processa Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Processa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with TechPrecision Common and Processa Pharmaceuticals

The main advantage of trading using opposite TechPrecision Common and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TechPrecision Common position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind TechPrecision Common and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.